
Bombay Super Hybrid Seeds Q2: margins compress sharply, PAT growth of 5% lags revenue surge
Bombay Super Hybrid Seeds' standalone revenue rose 219.8% YoY to ₹85.86 Cr in Q2 FY27 (vs ₹26.85 Cr in Q2 FY26), but standalone PAT grew just 5.1% YoY to ₹2.36 Cr (vs ₹2.24 Cr) — net profit margin fell to 2.75% from 8.36%, and EBITDA-level margin (PBT + finance cost + depreciation ÷ revenue) fell to roughly 4.6% from ~15.6% a year ago. Sequentially, revenue fell 52.97% and PAT fell 83.5% from Q1 FY27 (revenue ₹182.57 Cr, PAT ₹14.30 Cr); this QoQ drop is treated as a seasonality artifact of the hybrid-seed business, where sales concentrate ahead of the kharif sowing window in Q1, rather than as fresh weakness — the YoY comparison is the one that matters here. The gap between the 220% YoY revenue jump and the 5% PAT growth shows the incremental volume carried very thin margin this quarter: total expenses rose to ₹83.01 Cr from ₹24.49 Cr a year ago, driven by purchases/production costs and the change-in-inventories line scaling roughly in step with the higher sales base, while employee costs and depreciation rose only modestly and finance costs stayed close to last year's level. There is no exceptional item on either side of the YoY comparison, so the margin compression is read as operating, not accounting. There is no analyst coverage or consensus estimate for this stock (confirmed via search), so no beat/miss call versus street can be made, and the company has no formal guidance on record in our context or found via search, so management's own bar cannot be checked either. No results press release was available for this filing to cross-check management's framing. The quarter's other disclosed developments — a ₹3.68 Cr Indore property acquisition in August and the FY26 annual report submission/AGM approvals through September-October — are governance and capacity items that have not yet shown up in this quarter's P&L. H1 FY27 PAT of ₹16.66 Cr (on revenue of ₹269.04 Cr) is already about 62.5% of full-year FY26 PAT (₹26.66 Cr), so the second half will determine whether the full year tracks ahead of FY26 despite the Q2 margin squeeze.
Key Highlights
- Standalone revenue surged 219.8% YoY to ₹85.86 Cr in Q2 FY27 (vs ₹26.85 Cr in Q2 FY26), but fell 52.97% QoQ from ₹182.57 Cr in Q1 FY27 — a seasonal pattern typical of the hybrid-seed business.
- Net profit rose just 5.1% YoY to ₹2.36 Cr (from ₹2.24 Cr), trailing revenue growth by a wide margin; PAT fell 83.5% QoQ from ₹14.30 Cr in Q1 FY27.
- Net profit margin compressed to 2.75% from 8.36% a year ago; EBITDA-level margin fell to ~4.6% from ~15.6% YoY, as expenses scaled roughly with the higher volume base.
- Basic EPS was ₹0.22 for the quarter (not annualised), versus ₹0.21 a year ago and ₹1.36 in Q1 FY27.
- No exceptional items in the current or year-ago quarter; auditor Gautam N Associates issued an unmodified review opinion on the unaudited standalone results.
- H1 FY27 standalone PAT of ₹16.66 Cr on revenue of ₹269.04 Cr, versus ₹14.51 Cr PAT on ₹179.99 Cr revenue in H1 FY26.
- No analyst/street coverage exists for the stock and no formal management guidance is on record, so no vs-street or vs-guidance call can be made this quarter.
Price Impact
More from BSHSL